Skip to content

Immunophenotyping of inflammatory cells in Atopic Dermatitis

Immunophenotyping of inflammatory cells in Atopic Dermatitis - Immunophenotyping in Atopic Dermatitis

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38740
Enrollment
Unknown
Registered
2013-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis eczema

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. AD group: - age range 18 to 70 years - AD according to diagnostic criteria of Hanifin and Rajka - patients for APT: sensitised to aeroallergens (previously shown to have a positive APT) 2. Psoriasis group - chronic plaque psoriasis patients, ages 18-70 years

Exclusion criteria

Exclusion criteria: - topical treatment of the biopsy region with corticosteroids or tacrolimus in the two weeks prior to taking the biopsies - treatment with systemic corticosteroids or other immunosuppressive medication in the four weeks prior to taking the biopsies - exposure of biopsy location to (extraordinary) UV sunlight (e.g. UV-therapy, sunny holiday) in in the two weeks prior to taking the biopsies

Design outcomes

Primary

MeasureTime frame
We will study the number of skin infiltrating cells per square millimetre skin in lesional AD skin, non-lesional AD skin, lesional psoriasis skin, non-lesional psoriasis skin and skin after atopy patch testing. This includes the analysis of: - T cells - B cells - NK cells - Dendritic cells - Eosinophils - Macrophages - Mast cells - Basophils - Neutrophils

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)